
    
      Original histopathologically proven diagnosis World Health Organization (WHO) Grade 3/4
      glioma patients who underwent surgery, chemoradiotherapy and adjuvant chemotherapy (Stupp
      Protocol). Recurrence based on Response Assessment in Neuro-Oncology (RANO) criteria and/or
      histopathology. Intervention included CyberKnife hypofractionated stereotactic radiotherapy
      (25Gy/5fx) with Anlotinib once daily (12mg/d) on days 1-14 of a 21-day cycle.
    
  